The European Commission has issued a draft decision to extend approval periods for some pesticide active substances. According to EC, due to the fact that the assessment of the substances has been delayed for reasons beyond the control of the applicants, the approvals of those active substances are likely to expire before a decision has been taken on their renewal. It is therefore necessary to extend their approval periods.
The approval periods of the active substances famoxadone, flumioxazine and metalaxyl-m were extended until 30 June 2019. The approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, ethephon, etoxazole, fenamiphos, fluoxastrobin, folpet, foramsulfuron, formetanate, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole and s-metolachlor were extended until 31 July 2019. The approval period of the active substance diuron was extended until 30 September 2019. The approval period of the active substance tebuconazole will expire on 31 August 2019.
Part A of the Annex to Implementing Regulation (EU) No 540/2011 is amended as follows:
(1) in the sixth column, expiration of approval, of row 35, Famoxadone, the date is replaced by ‘30 June 2020’;
(2) in the sixth column, expiration of approval, of row 37, Metalaxyl-M, the date is replaced by ‘30 June 2020’;
(3) in the sixth column, expiration of approval, of row 39, Flumioxazine, the date is replaced by ‘30 June 2020’;
(4) in the sixth column, expiration of approval, of row 44, Foramsulfuron, the date is replaced by ‘31 July 2020’;
(5) in the sixth column, expiration of approval, of row 46, Cyazofamid, the date is replaced by ‘31 July 2020’;
(6) in the sixth column, expiration of approval, of row 83, Alpha-cypermethrin, the date is replaced by ‘31 July 2020’;
(7) in the sixth column, expiration of approval, of row 84, Benalaxyl, the date is replaced by ‘31 July 2020’;
(8) in the sixth column, expiration of approval, of row 85, Bromoxynil, the date is replaced by ‘31 July 2020’;
(9) in the sixth column, expiration of approval, of row 86, Desmedipham, the date is replaced by ‘31 July 2020’;
(10) in the sixth column, expiration of approval, of row 88, Phenmedipham, the date is replaced by ‘31 July 2020’;
(11) in the sixth column, expiration of approval, of row 97, S-metolachlor, the date is replaced by ‘31 July 2020’;
(12) in the sixth column, expiration of approval, of row 99, Etoxazole, the date is replaced by ‘31 July 2020’;
(13) in the sixth column, expiration of approval, of row 109, Bifenazate, the date is replaced by ‘31 July 2020’;
(14) in the sixth column, expiration of approval, of row 110, Milbemectin, the date is replaced by ‘31 July 2020’;
(15) in the sixth column, expiration of approval, of row 141, Fenamiphos, the date is replaced by ‘31 July 2020’;
(16) in the sixth column, expiration of approval, of row 142, Ethephon, the date is replaced by ‘31 July 2020’;
(17) in the sixth column, expiration of approval, of row 145, Captan, the date is replaced by ‘31 July 2020’;
(18) in the sixth column, expiration of approval, of row 146, Folpet, the date is replaced by ‘31 July 2020’;
(19) in the sixth column, expiration of approval, of row 147, Formetanate, the date is replaced by ‘31 July 2020’;
(20) in the sixth column, expiration of approval, of row 148, Methiocarb, the date is replaced by ‘31 July 2020’;
(21) in the sixth column, expiration of approval, of row 149, Dimethoate, the date is replaced by ‘31 July 2020’;
(22) in the sixth column, expiration of approval, of row 150, Dimethomorph, the date is replaced by ‘31 July 2020’;
(23) in the sixth column, expiration of approval, of row 152, Metribuzin, the date is replaced by ‘31 July 2020’;
(24) in the sixth column, expiration of approval, of row 153, Phosmet, the date is replaced by ‘31 July 2020’;
(25) in the sixth column, expiration of approval, of row 154, Propamocarb, the date is replaced by ‘31 July 2020’;
(26) in the sixth column, expiration of approval, of row 156, Pirimiphos-methyl, the date is replaced by ‘31 July 2020’;
(27) in the sixth column, expiration of approval, of row 158, Beflubutamid, the date is replaced by ‘31 July 2020’;
(28) in the sixth column, expiration of approval, of row 163, Benthiavalicarb, the date is replaced by ‘31 July 2020’;
(29) in the sixth column, expiration of approval, of row 164, Boscalid, the date is replaced by ‘31 July 2020’;
(30) in the sixth column, expiration of approval, of row 166, Fluoxastrobin, the date is replaced by ‘31 July 2020’;
(31) in the sixth column, expiration of approval, of row 167, Paecilomyces lilacinus strain 251, the date is replaced by ‘31 July 2020’;
(32) in the sixth column, expiration of approval, of row 168, Prothioconazole, the date is replaced by ‘31 July 2020’;
(33) in the sixth column, expiration of approval, of row 192, Diuron, the date is replaced by ‘30 September 2020’;
(34) in the sixth column, expiration of approval, of row 268, Tebuconazole, the date is replaced by ‘31 August 2020’.
Source: Agropages
